Subscribe
Topics
AI & Technology
›
Sectors & Use Cases
›
AI Business Strategy
›
AI Leadership & Perspective
›
Agentic
Analytics
Automation
Blockchain
Cloud
Computer Vision
Conversational AI
Cyber Security
Data
Digital Transformation
Ethics & Responsibility
Future of AI
IoT
Machine Learning
Metaverse
Natural Language Processing (NLP)
Responsible AI
Robotics
All AI & Technology →
Automotive
Education
Energy
Finance
Gaming
Healthcare
Insurance
Manufacturing
Property & Real Estate
Public Sector
Retail
Sports
Supply Chain & Logistics
Telecommunications
All Sectors & Use Cases →
Digital Transformation
Environment & Sustainability
Ethics & Responsibility
HR, Workforce, and Skills
Legal & Compliance
Marketing & Customer
Product & Revenue
Policy & Regulation
All AI Business Strategy →
Boardroom & Governance
C-Suite Perspective
Community Voices
Founder & Investor Voices
Innovation Spotlight
Interview
Leadership Vision
Strategic Partnerships
All AI Leadership & Perspective →
Analysis
Interview
Community Voices
C-Suite Perspective
Boardroom & Governance
Leadership Vision
Founder & Investor Voices
Innovation Spotlight
CEO Conversations
Zhengyang Yang on the Design Choices Shaping AI Shopping
Directors Are Already Using AI. Governance Has to Catch Up.
All Analysis →
Columnists
Control Layer
Victor Dey
EasyA Wants AI Agents to Run Startups as It Prepares to Go Public
Darktrace CEO Says the Next Insider Threat Is an AI Agent You Approved
Synthesia Wants AI Avatars to Make Your Employees Better at Their Jobs
All Columnists →
Research
Research
Data
Analytics
Machine Learning
Responsible AI
Ethics & Responsibility
Policy & Regulation
Natural Language Processing (NLP)
Why better AI needs better biology
Revenue architecture security: preventing data leakage in AI-powered CPQ and CLM engines
All Research →
Events
Grafana Labs: ObservabilityCON 2025, London
Securonix: Gartner’s Security and Risk Management Summit, London
Uniphore: AI Leadership Summit
ABBYY: AI SUMMIT SERIES, LONDON
All Events →
Media Kit
Explore Topics
Latest
Agentic
Enterprise AI
Cyber Security
Policy & Regulation
Control Layer
Machine Learning
Data
Menu
Search for
Log In
Topics
AI & Technology
Agentic
Analytics
Automation
Blockchain
Cloud
Computer Vision
Conversational AI
Cyber Security
Data
Digital Transformation
Ethics & Responsibility
Future of AI
IoT
Machine Learning
Metaverse
Natural Language Processing (NLP)
Responsible AI
Robotics
Sectors & Use Cases
Automotive
Education
Energy
Finance
Gaming
Healthcare
Insurance
Manufacturing
Property & Real Estate
Public Sector
Retail
Sports
Supply Chain & Logistics
Telecommunications
AI Business Strategy
Digital Transformation
Environment & Sustainability
Ethics & Responsibility
HR, Workforce, and Skills
Legal & Compliance
Marketing & Customer
Product & Revenue
Policy & Regulation
AI Leadership & Perspective
Boardroom & Governance
C-Suite Perspective
Community Voices
Founder & Investor Voices
Innovation Spotlight
Interview
Leadership Vision
Strategic Partnerships
Columnists
The Control Layer By Victor Dey
Learn
Events
Newsletter
Reports & Guides
Webinars
Media Kit
Premium
Login
Contact Us
Search for
Home
/
Press Release
Press Release
Apr
- 2026 -
20 April
Business Wire
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
Read More »
20 April
Business Wire
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
Read More »
20 April
Business Wire
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
Read More »
20 April
Cision PR Newswire
Milvus Robotics Introduces the SEIT F1500S Forklift-Type Autonomous Mobile Robot for Advanced Material Handling
Read More »
20 April
Cision PR Newswire
Daqo New Energy Files Annual Report on Form 20-F for Fiscal Year 2025
Read More »
20 April
MarketersMEDIA Newswire
Online Induction Enhances Workplace Safety with Secure AI Innovation to Support Modern Workforce Management
Read More »
20 April
Business Wire
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
Read More »
20 April
Business Wire
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
Read More »
20 April
Business Wire
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
Read More »
20 April
Cision PR Newswire
Continuous Composites Expands Manufacturing Footprint to Support Production-Relevant CF3D Systems
Read More »
Previous page
Next page
Back to top button
Close
Search for
Close
Search for
Close
Log In
Forget?
Remember me
Log In
